Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2004
12/08/2004CN1179210C Method and device for control liquid motion
12/08/2004CN1179208C Sensors arrays for detecting analytes in fluids and its manufacturing method and use
12/08/2004CN1179070C Method for inspecting physical property of electro-depositing copper foil
12/08/2004CN1179047C Method for introducing substances into cells and use of said method
12/08/2004CN1179035C Simulated biological dissolution and absorption system
12/08/2004CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004CN1178952C Nucleic acids encoding G-protein coupled receptor involved in sensory transduction
12/08/2004CN1178751C Device for binding target molecule
12/07/2004US6829540 Data processing, drug screening using immobilized artificial membrane chromatographic substrates in high pressure liquid chromatographic systems using aqueous mobile phases
12/07/2004US6829539 Determining amino acid sequence of preferential polypeptide; obtain polypeptide, generate mass spectrum data, analyse, determine amino acid sequence
12/07/2004US6828800 Single-molecule detector
12/07/2004US6828555 Three-dimensional structure verification supporting apparatus, three-dimensional structure verification method, recording medium, and program therefor
12/07/2004US6828430 For prognosis/treatment; poly(A) binding protein II (PAB II)
12/07/2004US6828428 IGA nephropathy-related genes
12/07/2004US6828424 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent
12/07/2004US6828421 VAMP-associated protein A-interacting proteins and use thereof
12/07/2004US6828420 Small conductance, calcium-activated potassium channels (SKI)
12/07/2004US6828416 Recombinant multivalent malarial vaccine against Plasmodium falciparum
12/07/2004US6828350 Inhibiting the activity of a picornavirus 3C protease or a cysteine protease with a composition having an orthohydroxy keto aryl core structure
12/07/2004US6828159 Carbopyronine fluorescent dyes
12/07/2004US6828158 Mixture of first and second microparticles having mean diameters and refractive indexes, particles are coated with first and second binding partners for analyte, first particles having stronger light scattering properties than second
12/07/2004US6828157 Products and methods for single parameter and multiparameter phenotyping of cells
12/07/2004US6828155 Method for evaluating lipid a analog-containing injections
12/07/2004US6828152 Reagentless method for determining the concentration of one or more analytes in blood, synovial fluid, semen, feces and cerebrospinal fluid via spectrophotometry; hemolysis
12/07/2004US6828145 Selecting cells that express a known marker, such as proteins expressed by genes encoding the major histocomatibility complex
12/07/2004US6828142 Nanocrystal for use in the signaling and signal amplification for detecting target molecules
12/07/2004US6828123 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
12/07/2004US6828122 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
12/07/2004US6828116 Energy transfer assay method and reagent
12/07/2004US6828114 Monoclonal antibody against apolipoprotein A-I
12/07/2004US6828113 IgM antibodies to the 70 kDa heat shock protein as a marker for cytomegalovirus infection
12/07/2004US6828112 Monitoring protein preferential protein activities; obtain cell, transform cell with vector, express vector, monitor cell for reporter molecule expression
12/07/2004US6828110 Assays for detection of Bacillus anthracis
12/07/2004US6828109 Screening for preferential particle in solution; obtain cells, fix, catalyze deposition of tyramide, incubate with detectable label, detect signal
12/07/2004US6828107 Immunoassay method for BNP
12/07/2004US6828106 Detection and monitoring activity of preferential protease enzyme; provide polypeptide binding domain, digest, allow binding, detect signal, incubate with protease, detect modulation of signal
12/07/2004US6828105 Methods of their use in inhibition of growth of viruses of the picornavirus, calicivirus, togavirus and flavivirus families, as in treatment of a viral infection. The antisense antiviral compounds are substantially uncharged oligomers having a
12/07/2004US6828100 Method of DNA sequencing
12/07/2004US6828099 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression
12/07/2004US6828091 Detecting immunosuppressant; obtain cells, incubate with modulator, expose to substrate, measure caspase activity, adjustment in caspase activity indicates modulator of lymphocyte activity
12/07/2004US6827939 Amino acid sequences for use in detection and treatment of viral infection
12/07/2004US6827937 HBV capsid-binding peptide immunogens
12/07/2004US6827935 Method of and compositions for immunization with the pseudomonas V antigen
12/07/2004US6827925 Specific binding proteins including antibodies which bind to the necrotic center of tumors, and uses thereof
12/07/2004US6827903 Inert gas fusion analyzer
12/07/2004US6827899 Test device
12/07/2004US6827842 On-line determination of wax crystallization temperature of waxy solvent stream
12/07/2004US6827829 Test strip for a concentration measuring apparatus biosensor system
12/07/2004US6827763 Filter for a gas analyzer
12/07/2004US6827691 Ovulation-period-detecting reagents and the use thereof
12/07/2004US6827484 Cloud point monitoring device
12/07/2004US6827476 System for controlling mixing processes
12/07/2004US6826973 Heated mechanical arm
12/07/2004US6826972 Lysimeter methods and apparatus
12/07/2004CA2267659C Chronic fatigue syndrome diagnosis
12/07/2004CA2219529C Device for the collection, testing and shipment of body fluid samples
12/07/2004CA2217776C Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/07/2004CA2160850C Apparatus for testing lumber stiffness
12/07/2004CA2070961C Thiol-reactive maleimido-based radiolabeling reagents
12/06/2004CA2469992A1 Transgenic animal model for glyt1 function
12/06/2004CA2469969A1 Devices, system and methods for extracting bodily fluid and monitoring an analyte therein
12/06/2004CA2468638A1 Waste gas measuring device
12/04/2004CA2468014A1 Flow rate determination
12/04/2004CA2468009A1 Early result determination
12/02/2004WO2004105153A2 Micro/nano fluidic 3-dimensional electrode system
12/02/2004WO2004104598A1 Diagnostic kit for liver cirrhosis compring an antibody specific for human protooncogenic protein
12/02/2004WO2004104597A1 Method for the prediction, diagnosis and differential diagnosis of alzheimer's disease
12/02/2004WO2004104596A2 Diagnostics and therapeutics for diseases associated with igs70 (igs70)
12/02/2004WO2004104595A2 Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd)
12/02/2004WO2004104594A2 Light emitting probes
12/02/2004WO2004104593A1 Use of protein masp as a marker for colorectal cancer
12/02/2004WO2004104592A1 Use of protein masp as a marker for colorectal cancer
12/02/2004WO2004104591A2 Improvements to gamma delta t cell-mediated therapy
12/02/2004WO2004104590A1 Sample carrier based on a porous film with metal oxide particles, the production and utilization thereof, especially for selective detection of phosphorylated/sulphatized biopolymers
12/02/2004WO2004104589A1 Method for analyzing the influence of an active substance on biological cells
12/02/2004WO2004104588A1 Methods for protein labeling based on acyl carrier protein
12/02/2004WO2004104586A1 Allergen test devices and methods for their use
12/02/2004WO2004104585A1 Polymeric microarray support, method of forming microfeatures and on optical assay arrangement
12/02/2004WO2004104583A1 Method of analyzing physiological function of target substance
12/02/2004WO2004104582A1 Method of measuring dna methylation ratio
12/02/2004WO2004104581A1 Method of determining efficacy of anticancer drug and determination kit therefor
12/02/2004WO2004104580A1 Device and methods for coupling/ uncoupling a target or an object present in a sample
12/02/2004WO2004104579A1 Method for the detection of fluoride or hydrogen fluoride and detection kit
12/02/2004WO2004104578A1 Method of screening inhibitor by using induction of interleukin 18 production by keratinocyte, method of inducing atopic dermatitis-like symptom and utilization of the same
12/02/2004WO2004104577A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4)
12/02/2004WO2004104576A1 Device for conveying a fluid volume, device and method for the analysis thereof
12/02/2004WO2004104575A2 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2)
12/02/2004WO2004104574A2 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 7 (ccr7)
12/02/2004WO2004104569A1 Biosensor for analyzing quantitatively analyte with a predetermined size and larger than and manufacturing method thereof
12/02/2004WO2004104558A1 Testing of fabricated fluoropolymer articles for metal contamination
12/02/2004WO2004104554A2 Organic analysis module
12/02/2004WO2004104552A2 Apparatus and method for process monitoring
12/02/2004WO2004104549A2 Identification and quantification of organ-specific proteins derived from human allogeneic cells using proteomics
12/02/2004WO2004104230A1 Reducing microarray variation with internal reference spots
12/02/2004WO2004104224A2 Markers for lxr activation
12/02/2004WO2004104223A1 Method for the covalent immobilisation of probe biomolecules on organic surfaces
12/02/2004WO2004104221A2 Methods and kits for quantifying metabolites or analytes
12/02/2004WO2004104218A1 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase (aminopeptidase p) 1 (xpnpep1)
12/02/2004WO2004104217A2 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases
12/02/2004WO2004104216A2 Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)